Company Filing History:
7 out of 60 
3 out of 16 
2 out of 30 
Years Active: 2013-2023
Title: Hugo Katus: A Pioneer in Cardiovascular Research
Introduction
Hugo Katus, an esteemed inventor based in Heidelberg, Germany, has made significant contributions to the field of cardiovascular research. With a robust portfolio of 15 patents, Katus's innovative work focuses on improving treatments for cardiovascular diseases and advancing medical science.
Latest Patents
Some of Katus's most recent patents highlight his groundbreaking research. One notable invention involves NFAT binding polynucleotides, which are designed to comprise a Nuclear factor of activated T-cells (NFAT) binding site sequence, along with a reverse complement of the NFAT binding site sequence separated by a spacer. This polynucleotide is intended for use in treating and/or preventing diseases, specifically targeting NFAT-mediated diseases through viral particles and compositions.
Another significant patent centers around ABHD5 and partial HDAC4 fragments and variants, presenting a novel therapeutic approach for treating cardiovascular diseases. This invention emphasizes the potential use of Abhydrolase containing domain 5 (ABHD5) and N-terminal fragments of HDAC4 (HDAC4-NT) in treating heart failure. The innovations include vectors for cardiomyocyte-specific expression of these peptides and a test system utilizing ABHD5 for the identification of valuable compounds for heart failure treatment.
Career Highlights
Throughout his career, Hugo Katus has been associated with reputable institutions, notably Ruprecht-Karls-Universität Heidelberg. His position at this renowned university has enabled him to engage in cutting-edge research and contribute meaningfully to the medical community. Additionally, he has worked with Metanomics GmbH, where he further advanced his work on cardiovascular innovations.
Collaborations
Katus has collaborated with prominent colleagues in the field, including Benjamin Meder and Jens Fuhrmann. Their collective expertise has significantly enhanced the impact of their research, leading to groundbreaking discoveries in cardiovascular health and disease prevention.
Conclusion
Hugo Katus's commitment to innovation in cardiovascular research has resulted in a remarkable array of patents and collaborations. His inventions continue to shape the future of medical treatment for heart diseases, highlighting the essential role of inventors in advancing healthcare. As the field evolves, Katus’s contributions are likely to influence future research and therapeutic strategies in cardiology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.